| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/28/2023 | — | Berenberg | Initiates Coverage On | → Hold | |
| 09/20/2023 | 4.02% | Jefferies | → $52 | Initiates Coverage On | → Hold |
| 05/11/2023 | 8.02% | Wells Fargo | $52 → $54 | Maintains | Equal-Weight |
| 03/29/2023 | 0.02% | Credit Suisse | $55 → $50 | Maintains | Neutral |
| 12/09/2022 | 16.02% | Credit Suisse | $47 → $58 | Upgrades | Underperform → Neutral |
| 09/26/2022 | 22.02% | Truist Securities | $64 → $61 | Maintains | Hold |
| 06/21/2022 | 24.02% | BMO Capital | → $62 | Downgrades | Outperform → Market Perform |
| 04/19/2022 | 22.02% | BMO Capital | $63 → $61 | Maintains | Outperform |
| 02/01/2022 | 2.02% | Credit Suisse | → $51 | Initiates Coverage On | → Underperform |
| 01/07/2022 | 36.03% | BMO Capital | → $68 | Upgrades | Market Perform → Outperform |
| 07/23/2021 | 44.03% | Wells Fargo | $74 → $72 | Maintains | Equal-Weight |
| 06/18/2021 | 42.03% | BMO Capital | → $71 | Upgrades | Underperform → Market Perform |
| 03/30/2021 | 54.03% | Capital One | → $77 | Downgrades | Overweight → Equal-Weight |
| 01/13/2021 | 10.02% | Mizuho | → $55 | Downgrades | Neutral → Underperform |
| 01/08/2021 | — | BMO Capital | Downgrades | Market Perform → Underperform | |
| 12/14/2020 | — | Keybanc | Upgrades | Underweight → Sector Weight | |
| 09/02/2020 | 26.03% | Stifel | → $63 | Reinstates | → Hold |
| 06/24/2020 | 28.03% | SunTrust Robinson Humphrey | $61 → $64 | Maintains | Hold |
| 06/17/2020 | 32.03% | Wells Fargo | $54 → $66 | Maintains | Equal-Weight |
| 06/08/2020 | — | JMP Securities | Reinstates | → Market Perform | |
| 05/22/2020 | 10.02% | Mizuho | $60 → $55 | Downgrades | Buy → Neutral |
| 05/14/2020 | -19.98% | Keybanc | $43 → $40 | Maintains | Underweight |
| 04/23/2020 | 22.02% | SunTrust Robinson Humphrey | $77 → $61 | Maintains | Hold |
| 04/21/2020 | -13.98% | Keybanc | $65 → $43 | Maintains | Underweight |
| 03/26/2020 | 2.02% | Wells Fargo | $82 → $51 | Maintains | Equal-Weight |
| 02/05/2020 | — | Berenberg | Initiates Coverage On | → Buy | |
| 01/07/2020 | 64.03% | BMO Capital | → $82 | Upgrades | Underperform → Market Perform |
| 12/20/2019 | 90.04% | Mizuho | → $95 | Assumes | → Buy |
| 02/20/2019 | — | BMO Capital | Downgrades | Market Perform → Underperform |
What is the target price for National Health Investors (NHI)?
There is no price target for National Health Investors
What is the most recent analyst rating for National Health Investors (NHI)?
There is no analyst for National Health Investors
When is the next analyst rating going to be posted or updated for National Health Investors (NHI)?
There is no next analyst rating for National Health Investors
Is the Analyst Rating National Health Investors (NHI) correct?
There is no next analyst rating for National Health Investors